Drug Discovery & Development

Genomics/Proteomics

Subscribe to Genomics/Proteomics
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Data Demonstrates GSO Technology

May 3, 2011 6:56 am | News | Comments

A study describes how gene-silencing oligonucleotides (GSOs) from Idera Pharmaceuticals efficiently inhibited gene expression while overcoming some of the issues associated with other gene-silencing technologies.

Researchers Identify Genes Causing Antimalarial Drug Resistance

April 22, 2011 7:17 am | News | Comments

Researchers have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments.

Scientists Observe Single Gene Activity in Living Cells

April 22, 2011 7:13 am | News | Comments

Researchers have for the first time observed the activity of a single gene in living cells, following the process of gene transcription.

Advertisement

Telomeres Protected by DNA Caps

April 21, 2011 8:11 am | News | Comments

Researchers have demonstrated how telomeres can be protected by caps made up of specialized proteins and stacks of DNA called G-quadruplexes, or G4 DNA.

A New Roadmap

April 8, 2011 7:28 am | by John A. Wass, PhD, Consulting Statistician; Quantum Cat Consultants, Lake Forest, Ill.; Cele Abad-Zapatero, PhD, Adjunct Professor, Center for Pharmaceutical Biotechnology; University of Illinois at Chicago | Articles | Comments

For many years now, researchers and business analysts have observed the number of new drug approvals fall as the money spent in developing these drugs has risen sharply.

DNA Sequencing: From Revolutionary to Routine

April 8, 2011 6:42 am | by Alan Dove, PhD, Contributing Editor | Articles | Comments

DNA sequencing has become a common laboratory chore, and companies are increasingly outsourcing it to contractors. Here’s how to pick a good one.

Detecting Multiple miRNA Markers with Microarrays

April 5, 2011 10:40 am | by John Keefe, Sr. Product Manager-RNA; Affymetrix, Santa Clara, Calif. | Articles | Comments

Small non-coding RNA has become a very important class of molecules for understanding cellular development, differentiation, and the mechanisms of disease for genetic disorders such as cancer.

Small RNA Discovery and Profiling with Next-Generation Sequencing

April 5, 2011 10:32 am | Articles | Comments

As next-generation sequencing continues to evolve as a research tool, it is being adopted for examining gene regulation at the transcriptional and post-transcriptional levels.

Advertisement

A Long Way to the Bedside

March 9, 2011 10:13 am | by Catherine Shaffer, Contributing Editor | Articles | Comments

Recent years have seen rapid technological progress in the fields supporting personalized medicine, from biomarker discovery to mapping the genome to pushing back the frontiers of mass spec sensitivity.

Roche, RainDance Collaborate in Targeted Sequencing for ADME Research

March 7, 2011 7:04 am | News | Comments

RainDance Technologies, Inc., and 454 Life Sciences announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the investigation of drug absorption, distribution, metabolism, and excretion (ADME).

Advanced Imaging Software for Western Blot Analysis

January 13, 2011 5:06 am | by Stephanie R. Noles, PhD, Global In Vitro Product Manager Carestream Molecular Imaging, Woodbridge, Conn. | Articles | Comments

Protein analysis has quickly become as integral a component of the drug discovery process as genomics. The examination of protein expression levels and post-translational modifications helps identify new drug targets.

Fluorescent Western Blotting: A Quantitative Approach

January 13, 2011 4:54 am | by Amy Schutz-Geschwender, PhD, Principal Scientist; LI-COR Biosciences, Lincoln, Neb. | Articles | Comments

For decades, researchers have used Western blotting to confirm the presence of a target protein in a complex sample. After gel electrophoresis, proteins are transferred to a membrane and interrogated with antibodies.

High Throughput Western Blotting

January 13, 2011 4:32 am | by Jeff Xu, Product Manager, Blotting and Stains, Bio-Rad Laboratories, Inc., Hercules, Calif. | Articles | Comments

Western blotting involves the transfer of proteins from a gel matrix to a membrane following protein electrophoresis. This process serves as a bridge between protein separation and identification.

New Test Aids Breast Cancer Patients

December 6, 2010 7:18 am | News | Comments

A team of scientists has collaborated with Pfizer Inc. to develop a test to select which patients with ovarian cancer will benefit from drugs called PARP inhibitors, according to research.

Cancer GWAS and Data Analysis Grant Program

November 9, 2010 4:43 am | News | Comments

Expression Analysis and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.

Sigma Partnering With JAX to Distribute Mouse Models

November 4, 2010 8:22 am | News | Comments

Sigma Life Science and The Jackson Laboratory, a not-for-profit genetics research institution, announced a joint agreement allowing JAX to distribute mouse models created using Sigma Life Science’s proprietary zinc finger nuclease technology.

The Search for CNS Cures

October 14, 2010 12:58 pm | Digital Editions | Comments

Advances in medicine and healthcare are helping people live longer. However, healthcare systems and governments may not be prepared to deal with the medical, economic, and social challenges of an aging population.

Personal Genetic Profiling Services Lack Evidence For Claims

October 13, 2010 8:32 am | News | Comments

Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the results are based.

Laying the IT Foundations

October 11, 2010 7:36 am | by David Chiang, Chief Executive Officer, Sage-N Research, Milpitas, Calif. | Articles | Comments

The development of effective data analysis and storage solutions for high-throughput mass spectrometry.

Genomic and Metabolic Data Harnessed to Fight TB

October 8, 2010 6:49 am | News | Comments

Researchers at the Institute for Genomic Biology at the University of Illinois have developed a way to harness the prodigious quantities of both genomic and metabolic data being generated with high-throughput genomics and other techniques.

An X-ray for Your Genes

October 8, 2010 6:45 am | News | Comments

Not every patient reacts to a medicine in the same way. The personal genetic characteristics of individuals and populations can explain why a specific prescription successfully treats one patient and not another.

Human Genome Sequencing on a Grand Scale

September 15, 2010 6:29 am | by Radoje Drmanac, PhD, Chief Scientific Officer and Co-founder; Complete Genomics, Inc., Mountain View, Calif. | Articles | Comments

Genetic variations—the way in which genes and proteins differ between individuals—can have important medical consequences. As a result, complete human genome sequencing has many potential drug discovery applications.

NGS Delivers Fundamental Research Shift

September 15, 2010 6:20 am | by Elaine Wong-Ho, Associate Product Marketing Manager; Caliper Life Sciences, Hopkinton, Mass. | Articles | Comments

The three current NGS platforms share a common feature—massively parallel sequencing of spatially separated, clonally amplified DNA molecules. This is fundamentally different than Sanger technology, in which individual sequencing reactions are separated by capillary electrophoresis.

The Blueprints for Personalized Medicine: A Genome Approach

September 15, 2010 5:50 am | by Edward L. Erickson, President and CEO; BioNanomatrix, Inc., Philadelphia, Pa. | Articles | Comments

Researchers are constantly searching for a better understanding of fundamental disease mechanisms and tools for early diagnosis and even pre-diagnosis of disease.

Ambry Adds HiSeq and BeadXpress Instruments

August 27, 2010 8:19 am | News | Comments

Ambry Genetics, a global leader in genomic services, announced that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading